Janel Long-Boyle, PharmD, PhD

Associate Professor
Phone: +1 415 640-1569

600 16th St, Rm N474F
UCSF Box 0622
San Francisco, CA 94158
United States

Educational programs

UCSF centers, institutes, and research programs

What I do

I am a translational scientist with research interests that include pediatric cancer therapeutics, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial design. The majority of my research is focused around the chemotherapeutic and immunosuppressive agents used in the conditioning regimens of pediatric hematopoietic cell transplantation (HCT). Specifically, I am interested in how patient specific covariates such as age, renal function, or genetic variants involved in drug metabolism or distribution may influence drug clearance in the pediatric HCT population.

Research area

My research expertise

Pharmacokinetics, Pharmacodynamics, Pediatric pharmacology, Pediatric hematology, Oncology, Bone marrow transplantation

Clinical expertise

Hematology, Oncology, Bone marrow transplantation

Degrees

PhD, Experimental and Clinical Pharmacology, University of Minnesota, 2009
PharmD, University of Minnesota, 2006
BS, Biochemistry, University of Minnesota, 2000

Biography

Dr. Boyle is a translational scientist with research interests that include pediatric cancer therapeutics, pharmacokinetics, pharmacodynamics, pharmacogenomics, and clinical trial design. The majority of her research resides within the complex setting of hematopoietic cell transplantation (HCT) and is focused around chemotherapeutic and immunosuppressive agents used in the preparative regimens of pediatric HCT. Specifically, Dr. Boyle studies how covariates such as age, renal function, or genetic variants involved in drug metabolism or distribution may influence drug clearance in the pediatric HCT population.

Licensure and certifications

Licentiate in Pharmacy, Minnesota, 2006
Licentiate in Pharmacy, California, 2010